Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00292942 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety of Intravenous Artesunate
A Phase 1 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00292942 is a Phase 1 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 26 participants.
The verdict
NCT00292942, a Phase 1 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the safety, tolerability, and pharmacokinetics of a multiple dose of the antimalarial drug artesunate.
Interventions
- DRUG Placebo
- DRUG Intravenous Artesunate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-06-12 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00292942
The ClinicalTrials.gov registry entry for NCT00292942 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00292942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00292942 about?
NCT00292942 is a clinical study titled "Study of the Safety of Intravenous Artesunate". The purpose of this study is to establish the safety, tolerability, and pharmacokinetics of a multiple dose of the antimalarial drug artesunate.
What is the current status of trial NCT00292942?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2006-06-12. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00292942?
The interventions under investigation include: Placebo (DRUG), Intravenous Artesunate (DRUG).
Who is sponsoring clinical trial NCT00292942?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.